AbbVie to pay Abbott as contract drug manufacturer

Anonymous

Guest
AbbVie will utilize the manufacturing operations of Abbott to source it's drugs, information released today.

"The size of the contract manufacturing operations is not broken out in the prospectus, although a report on Outsourcing-Pharma estimates it could make around $420 million a year.

AbbVie's contract manufacturing business will sign "one or more manufacturing and supply agreements with Abbott" as part of the separation process, and will ‘manufacture, label and package’ products for its sibling.

The manufacturing and supply agreements will have a term of up to five years, and payments will be determined on ‘an arm's length basis’, according to the filing."

http://www.inpharm.com/news/172969/abbott-sets-out-abbvie-stall-shareholders


Real news pushing the stupid stuff off page 1, so you stay informed.
 






















AbbVie will utilize the manufacturing operations of Abbott to source it's drugs, information released today.

"The size of the contract manufacturing operations is not broken out in the prospectus, although a report on Outsourcing-Pharma estimates it could make around $420 million a year.

AbbVie's contract manufacturing business will sign "one or more manufacturing and supply agreements with Abbott" as part of the separation process, and will ‘manufacture, label and package’ products for its sibling.

The manufacturing and supply agreements will have a term of up to five years, and payments will be determined on ‘an arm's length basis’, according to the filing."

http://www.inpharm.com/news/172969/abbott-sets-out-abbvie-stall-shareholders


Real news pushing the stupid stuff off page 1, so you stay informed.

Like the CMO posting. Reading comprehension must not be your strong suit.

From a manufacturing perspective, Abbott underwent a major restructuring of its facilities in 2011 and AbbVie will start operations with five principal plants in North America and four main locations overseas.

The North American plants include two in Illinois, two in Puerto Rico and one in Massachusetts, accompanied by two units in Ireland and one apiece in Germany and Italy, according to the filing.

The size of the contract manufacturing operations is not broken out in the prospectus, although a report on Outsourcing-Pharma estimates it could make around $420 million a year.

AbbVie's contract manufacturing business will sign "one or more manufacturing and supply agreements with Abbott" as part of the separation process, and will ‘manufacture, label and package’ products for its sibling.

Abbott will be paying AbbVie for manufacturing, not the other way around.